BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di Natale C, La Manna S, De Benedictis I, Brandi P, Marasco D. Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic. Front Pharmacol 2020;11:578382. [PMID: 33343349 DOI: 10.3389/fphar.2020.578382] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Ling L, Zhang Z, Marin-lopez A. Current Advances in Zika Vaccine Development. Vaccines 2022;10:1816. [DOI: 10.3390/vaccines10111816] [Reference Citation Analysis]
2 Krut’ VG, Chuvpilo SA, Astrakhantseva IV, Kozlovskaya LI, Efimov GA, Kruglov AA, Drutskaya MS, Nedospasov SA. Will Peptides Help to Stop COVID-19? Biochemistry Moscow 2022;87:590-604. [DOI: 10.1134/s0006297922070021] [Reference Citation Analysis]
3 Sukaina M, Ali N, Waheed M, Hasan MM, Essar MY. Emergence of Omicron BA.1 and BA.2 variants and concern over vaccine breakthrough infection. Annals of Medicine and Surgery 2022;79:103941. [DOI: 10.1016/j.amsu.2022.103941] [Reference Citation Analysis]
4 Patil PJ, Sutar SS, Usman M, Patil DN, Dhanavade MJ, Shehzad Q, Mehmood A, Shah H, Teng C, Zhang C, Li X. Exploring bioactive peptides as potential therapeutic and biotechnology treasures: A contemporary perspective. Life Sci 2022;301:120637. [PMID: 35568229 DOI: 10.1016/j.lfs.2022.120637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bagwe PV, Bagwe PV, Ponugoti SS, Joshi SV. Peptide-Based Vaccines and Therapeutics for COVID-19. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10397-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Biswas S, Dey S, Chatterjee S, Nandy A. Combatting future variants of SARS-CoV-2 using an in-silico peptide vaccine approach by targeting the spike protein. Medical Hypotheses 2022;161:110810. [DOI: 10.1016/j.mehy.2022.110810] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Kalita P, Tripathi T. Methodological advances in the design of peptide-based vaccines. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Musumeci D, Ullah S, Ikram A, Roviello GN. Novel insights on nucleopeptide binding: A spectroscopic and in silico investigation on the interaction of a thymine-bearing tetrapeptide with a homoadenine DNA. Journal of Molecular Liquids 2022;347:117975. [DOI: 10.1016/j.molliq.2021.117975] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
9 Mohammed SA, Shaaban EIA. Efficacious nanomedicine track toward combating COVID-19. Nanotechnology Reviews 2022;11:680-98. [DOI: 10.1515/ntrev-2022-0036] [Reference Citation Analysis]
10 La Manna S, De Benedictis I, Marasco D. Proteomimetics of Natural Regulators of JAK-STAT Pathway: Novel Therapeutic Perspectives. Front Mol Biosci 2021;8:792546. [PMID: 35047557 DOI: 10.3389/fmolb.2021.792546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Noé A, Ewer K. Vaccines against SARS-CoV-2. Vaccinology and Methods in Vaccine Research 2022. [DOI: 10.1016/b978-0-323-91146-7.00001-9] [Reference Citation Analysis]
12 Shukla P, Pandey P, Prasad B, Robinson T, Purohit R, D'Cruz LG, Tambuwala MM, Mutreja A, Harkin J, Rai TS, Murray EK, Gibson DS, Bjourson AJ. Immuno-informatics analysis predicts B and T cell consensus epitopes for designing peptide vaccine against SARS-CoV-2 with 99.82% global population coverage. Brief Bioinform 2021:bbab496. [PMID: 34962259 DOI: 10.1093/bib/bbab496] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ferreira CS, Martins YC, Souza RC, Vasconcelos ATR. EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes. PeerJ 2021;9:e12548. [PMID: 34909278 DOI: 10.7717/peerj.12548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 La Manna S, Di Natale C, Onesto V, Marasco D. Self-Assembling Peptides: From Design to Biomedical Applications. Int J Mol Sci 2021;22:12662. [PMID: 34884467 DOI: 10.3390/ijms222312662] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
15 Susithra Priyadarshni M, Isaac Kirubakaran S, Harish MC. In silico approach to design a multi-epitopic vaccine candidate targeting the non-mutational immunogenic regions in envelope protein and surface glycoprotein of SARS-CoV-2. J Biomol Struct Dyn 2021;:1-16. [PMID: 34528491 DOI: 10.1080/07391102.2021.1977702] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Palma M. Perspectives on passive antibody therapy and peptide-based vaccines against emerging pathogens like SARS-CoV-2. Germs 2021;11:287-305. [PMID: 34422699 DOI: 10.18683/germs.2021.1264] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, Bell JC, Doti N, Velasco-Velázquez MA, de Jong D, de Jonge J, Smit J, Dömling A, van Goor H, Groves MR. Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein. J Med Chem 2021. [PMID: 34328726 DOI: 10.1021/acs.jmedchem.1c00477] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
18 Di Natale C, Battista E, Lettera V, Reddy N, Pitingolo G, Vecchione R, Causa F, Netti PA. Easy Surface Functionalization and Bioconjugation of Peptides as Capture Agents of a Microfluidic Biosensing Platform for Multiplex Assay in Serum. Bioconjug Chem 2021. [PMID: 34114801 DOI: 10.1021/acs.bioconjchem.1c00146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Askari Rizvi SF, Zhang H. Emerging trends of receptor-mediated tumor targeting peptides: A review with perspective from molecular imaging modalities. Eur J Med Chem 2021;221:113538. [PMID: 34022717 DOI: 10.1016/j.ejmech.2021.113538] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
20 Bisgin A, Sanlioglu AD, Eksi YE, Griffith TS, Sanlioglu S. Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination. Hum Gene Ther 2021;32:541-62. [PMID: 33858231 DOI: 10.1089/hum.2021.052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
21 Nel AE, Miller JF. Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape. ACS Nano 2021;15:5793-818. [PMID: 33793189 DOI: 10.1021/acsnano.1c01845] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 23.0] [Reference Citation Analysis]
22 Vivekanandhan K, Shanmugam P, Barabadi H, Arumugam V, Daniel Raj Daniel Paul Raj D, Sivasubramanian M, Ramasamy S, Anand K, Boomi P, Chandrasekaran B, Arokiyaraj S, Saravanan M. Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives. Front Mol Biosci 2021;8:604447. [PMID: 33763450 DOI: 10.3389/fmolb.2021.604447] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]